WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and ...
This allows brands to develop breakthrough hair serums more quickly and more consistently across global markets. Industry ...
Biologics are incredibly powerful and targeted. For these reasons, pharmaceutical companies have invested a lot of time and money over the past 20 years developing medications based on these compounds ...
Chemitek Solar develops biodegradable Drone AgroPV Cleaning Agent for drone-based cleaning of agrivoltaic systems ...
OYE Therapeutics has been authorized to initiate clinical development of its OYE-101 caffeine injection after the U.S. FDA cleared its Investigational New Drug applications. OYE-101 is a novel ...
Nine recommendations for extending therapeutic indications reflect ongoing lifecycle management and utility expansion of ...
The Ministry of Planning, Economic Development and International Cooperation has issued its 2025 Annual Report—for the sixth consecutive year—under the title “Jobs, Growth and Resilience: Delivering ...
Injectable dermal products have become some of the most sought-after cosmetic treatments. But behind every injection lies a ...
This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities ...
Aircraft wing-shaped structures inside tiny channels produce consistent drug delivery particles at any scale, from small laboratory tests to factory production, while substantially cutting costs.
Newcastle University engineers are at the forefront of adhesive technology that promises to change how we recycle.
Veradermics is set to raise $200 million in an IPO to fund its novel extended-release oral minoxidil for pattern hair loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results